These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6469388)

  • 1. An immunochemical method for assessing the function of the alternative complement pathway.
    Yoshida K; Yukiyama Y; Hirose S
    Int Arch Allergy Appl Immunol; 1984; 75(2):173-8. PubMed ID: 6469388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of complement activity in turkeys: evidence for classical and alternative complement pathways.
    Ellis MG; Lamont SJ; Arp LH
    Poult Sci; 1989 May; 68(5):646-50. PubMed ID: 2666975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical studies of complement activation.
    Garrigue MA; Muh JP; Bardos P
    Clin Chim Acta; 1983 Aug; 132(2):117-25. PubMed ID: 6616867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative pathway fof bovine complement Immunochemical studies on factor B-like serum protein and its conversion product B gamma 2.
    Tabel H
    Can J Comp Med; 1981 Jul; 45(3):291-8. PubMed ID: 6176300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of activation of the human terminal complement pathway by ELISA.
    Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA
    J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C9 hemolytic activity of the soluble C5b-9 complex of guinea pig complement, analogous to human SC5b-9.
    Kinoshita T; Hong K; Inoue K
    J Immunol; 1979 Nov; 123(5):1989-95. PubMed ID: 114583
    [No Abstract]   [Full Text] [Related]  

  • 12. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracts of wheat gluten activate complement via the alternative pathway.
    Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
    Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of optimal reaction conditions for an assay of the human alternative complement pathway.
    Joiner KA; Hawiger A; Gelfand JA
    Am J Clin Pathol; 1983 Jan; 79(1):65-72. PubMed ID: 6849295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative pathway of bovine complement: concentration of factor B, hemolytic activity and heritability.
    Tabel H; Menger M; Aston WP; Cochran M
    Vet Immunol Immunopathol; 1984 Mar; 5(4):389-98. PubMed ID: 6428035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunoabsorbent assay for the quantitation of the terminal complement complex from cell membranes or in activated human sera.
    Gawryl MS; Simon MT; Eatman JL; Lint TF
    J Immunol Methods; 1986 Dec; 95(2):217-25. PubMed ID: 3794343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A; Rowan-Kelly B
    Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor B of the alternative pathway of complement. Assessment by rocket immunoelectrophoresis.
    Kajdacsy-Balla A; Doi EM; Bagasra O
    Am J Clin Pathol; 1987 Jul; 88(1):66-73. PubMed ID: 3649166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.